News
Hospitalist/Intensivist Model Lowers Costs, Maintains Quality of Care
September 1, 2010
As the field of HM continues to mature, branch out, and is called upon to lead in the care of a larger cross-section of hospitalized patients, it is only natural that this includes the critically ill patient.
News
Market Watch
September 1, 2010
New Generics Desloratadine tablets (generic Clarinex)1 Didanosine delayed-release capsules (Generic Videx EC)2 New Indications, Dosage Forms, and Recommendations Ganciclovir ophthalmic gel 0.15% (Zirgan) has been approved by the FDA for treating acute herpetic keratitis.3 The recommende
![1]()
News
Productivity Capacity
September 1, 2010
The beginning of what’s next in HM
News
Market Watch
August 2, 2010
New Drugs, Indications, Dosage Forms, and Approvals Hydromorphone extended-release tablets (Exalgo) have been approved by the FDA as a once-daily treatment for managing moderate to severe pain in opioid-tolerant patients needing continuous opioid analgesia for an extended period of time.1 This f
![1]()
News
Change You Should Believe In
July 1, 2010
Care transitions challenge hospitalists to improve systems, communication
![1]()
News
Transitions Telethon
June 1, 2010
An idea to help eliminate frustrations with HM care
![1]()
News
Esse Est Percipi
May 2, 2010
New MOC affords HM to become who we say we are
News
Jam-Packed & Well Worth It
May 1, 2010
A day in the life of one hospitalist’s annual meeting
News
Quality Session
May 1, 2010
“Quality Improvement Curriculum: How to Get Started and to Keep Going”
News
Quality Session
May 1, 2010
“The Value Proposition to C-Suites: Aligning Hospital Resources to Support Hospitalist QI”
